Boardroom Alpha
Meeting calendar
TAP · Annual meeting · Wednesday, May 6, 2026

Molson Coors Beverage Co

14 nominees · 3 ballot items.

Elect 14 directors (11 Class A and 3 Class B); advisory approval of named executive officer compensation (say-on-pay); and ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026.

Market cap
$7.4B
1Y TSR
-17.0%
Board grade
C-
Record date
Mar 13, 2026
Filing
DEF 14A
Meeting concluded · May 6, 2026

Follow how the vote landed and what changed on Molson Coors Beverage Co’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot3

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of 14 director nominees (11 Class A nominees and 3 Class B nominees) to the Board.

  2. 2

    Advisory Vote to Approve Named Executive Officer Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding, advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement.

    More detail

    This management proposal asks stockholders to cast a non-binding, advisory vote approving the Company’s disclosed named executive officer (NEO) compensation package. Management seeks stockholder endorsement to validate its pay-for-performance framework, which combines short-term MCIP incentives tied to Underlying Income Before Income Taxes, Underlying Free Cash Flow and Underlying Net Sales Revenue, with long-term incentives (PSUs, RSUs and options) tied to multi-year earnings and Relative TSR. The Compensation & HR Committee retained an independent consultant, used a peer group for benchmarking, and implemented clawback and ownership guidelines to align interests with stockholders. The context includes a 2025 CEO transition, retention awards tied to leadership continuity, and mixed operative results (low annual MCIP payout but above-target PSU outcomes for the three‑year period), which management argues justify the overall program design. The Board recommends a FOR vote, stating that the program appropriately balances short- and long-term incentives, ties pay to key operational metrics and shareholder returns, and supports retention through a leadership transition. Key governance features referenced by the Board include annual advisory votes, independent committee oversight, a majority-independent board, and explicit disclosure of performance outcomes in the CD&A. A vote FOR is advisory only; the Board will consider the outcome when shaping future compensation but is not bound to it. From an investor-analytic perspective, the proposal should be evaluated on whether the disclosed metrics, payout outcomes, governance safeguards, and extraordinary awards (e.g., retention or sign-on RSUs tied to CEO transition) deliver alignment with long-term shareholder value without encouraging undue risk-taking.

  3. 3

    Ratify Appointment of Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026

    ManagementBoard: FOR

    Ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026.

Director elections

Nominees on the ballot14

Independent
Tenure on this board
21.4 yrs
Also a director at
Cpi Card Group Inc (PMTS)
Independent
Tenure on this board
2.6 yrs
Ownership

Top institutional holders10

Latest 13F quarter
1DODGE COX10.4%18,523,049$798M
2VANGUARD CAPITAL MANAGEMENT LLC6.0%10,627,366$458M
3VANGUARD PORTFOLIO MANAGEMENT LLC5.1%9,041,848$389M
4STATE STREET CORP4.9%8,750,039$377M
5DIMENSIONAL FUND ADVISORS LP4.5%7,949,583$342M
6LSV ASSET MANAGEMENT3.3%5,921,078$255M
7BlackRock, Inc.2.9%5,131,904$221M
8AQR CAPITAL MANAGEMENT LLC2.6%4,690,755$202M
9Invesco Ltd.2.6%4,683,070$202M
10GEODE CAPITAL MANAGEMENT, LLC2.3%4,050,503$174M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Molson Coors Beverage Co 2026 annual meeting?
Molson Coors Beverage Co (TAP) holds its 2026 annual shareholder meeting on Wednesday, May 6, 2026.
What is the record date for the Molson Coors Beverage Co 2026 meeting?
The record date for the Molson Coors Beverage Co 2026 meeting is Friday, March 13, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Molson Coors Beverage Co's 2026 meeting?
The board is presenting 14 director nominees at the Molson Coors Beverage Co 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Molson Coors Beverage Co 2026 meeting?
Shareholders will vote on 3 proposals at the Molson Coors Beverage Co 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer